Search results
Eli Lilly Stock Jumps After It Signals Rise in Obesity and Diabetes Drugs Production
The Wall Street Journal· 34 minutes agoSupply constraints for a popular class of diabetes and obesity drugs limited **Eli Lilly**’s...
Eli Lilly’s stock jumps as first-quarter profit tops estimates amid strong sales of Mounjaro,...
Market Watch· 2 hours agoEli Lilly & Co. shares gained 7% premarket on Tuesday after the company reported first-quarter...
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
WTNH-TV New Haven· 10 minutes agoRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit. The drugmaker also hiked its for…
Eli Lilly lifts sales view by $2 billion on soaring weight-loss drug demand
Reuters· 45 minutes ago, opens new tab raised its annual revenue forecast by $2 billion on Tuesday due to strong demand and...
Ozempic: an expert separates fact from fiction
The Telegraph via Yahoo News· 5 hours agoThree years ago injecting yourself skinny seemed positively futuristic. Now, everyone from Oprah Winfrey and Elon Musk to your local hairdresser are...
Lilly Raises 2024 Guidance as Zepbound Flies Off Shelves
Bloomberg· 2 hours agoHave a confidential tip for our reporters? Eli Lilly & Co. raised its annual outlook for sales and...
Chasing Novo and Lilly: The obesity drugs that could challenge Wegovy and Zepbound
BioPharma Dive via Yahoo Finance· 7 hours agoLarge and small drugmakers are vying for a piece of what analysts view as one of the biggest market...
Metformin: Treatment for Newly Diagnosed Type 2 Diabetes
Healthline· 5 days agoMetformin is particularly effective for people with diabetes or prediabetes who have obesity and...
Eli Lilly beats profit estimates on diabetes and weight-loss drug strength
Reuters via Yahoo Finance· 2 hours agoApril 30 (Reuters) - Eli Lilly beat Wall Street estimates for first-quarter profit on Tuesday, helped by rising demand for its weight-loss treatment Zepbound and type 2 diabetes< ...
Experimental drug shields pancreas from type 1 diabetes attack
Medical Xpress· 22 hours agoThe drug's specificity for such cells may enable long-term use in humans with few side effects, say the researchers. Monoclonal antibodies are made by cloning, or making identical ...